Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-14A Phase 1, Multicentre, Open-label, Nonrandomised, First-in-human Study of OVM-200 as a Therapeutic Vaccine in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Ovarian Cancer, and Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-14A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
-
CLINICAL_TRIALS study record update · 2025-02-13High Impact Training to Patients with Prostate Cancer and Bone Metastases
-
CLINICAL_TRIALS study record update · 2025-02-13Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial
-
CLINICAL_TRIALS study record update · 2025-02-13A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-12Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-12Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
-
CLINICAL_TRIALS study record update · 2025-02-12Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer: a Phase III Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-02-11Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Prospective, Single Center and Paired-design Diagnostic Study
-
CLINICAL_TRIALS study record update · 2025-02-11Construction and Validation of a Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3: a Multicenter, Retrospective Study
-
CLINICAL_TRIALS study record update · 2025-02-11Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer: An Observational Study
-
CLINICAL_TRIALS study record update · 2025-02-11The Addictive Diagnostic Value of Apparent Diffusion Coefficients to PI-RADS 3-5 of Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-10177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High- and Very High-risk Prostate Cancer After Radical Treatment Using Locoregional Teleradiotherapy and Hormone Therapy
-
CLINICAL_TRIALS study record update · 2025-02-10Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
-
CLINICAL_TRIALS study record update · 2025-02-07Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
-
CLINICAL_TRIALS study record update · 2025-02-07Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-06Dual-Tracer Theranostic PET
-
CLINICAL_TRIALS study record update · 2025-02-06Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring
-
CLINICAL_TRIALS study record update · 2025-02-06Randomized Phase II Study Evaluating Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)
-
CLINICAL_TRIALS study record update · 2025-02-04Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
-
CLINICAL_TRIALS study record update · 2025-02-03A Prospective, Multicenter, Post-marketing Surveillance to Assess Safety of Zytiga (Abiraterone Acetate Tablets 250 mg) in Indian Patients With Metastatic, Castration Resistant Prostate Cancer as Per Locally Approved Prescribing Information
-
CLINICAL_TRIALS study record update · 2025-02-03Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
-
CLINICAL_TRIALS study record update · 2025-02-03A Multicenter, Two-arm, Prospective, Observational Study to Characterize the Tolerability of Treatment With Enzalutamide or Abiraterone Acetate (With Prednisone) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
-
CLINICAL_TRIALS study record update · 2025-02-03PRISMA-PET - Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging
-
CLINICAL_TRIALS study record update · 2025-02-03Randomized Phase II Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy